KIT and melanoma: Additionally, it has been found that KIT can be inhibited by microRNAs (including miR-221 and miR-222), leading to a blockage of differentiation and subsequent proliferation of melanoma cells, including miR-221 and miR-222), leading to blockade of melanoma cell differentiation and subsequent proliferation, which further suggests its role in melanoma progression [35].